Document is current
Any future updates will be listed below
-
Authors
Onaga, Ryutaro https://orcid.org/0000-0002-6422-4033
Enokida, Tomohiro
Okano, Susumu
Fujisawa, Takao
Tanaka, Nobukazu
Hoshi, Yuta
Kishida, Takuma
Tanaka, Hideki
Sato, Masanobu
Takeshita, Naohiro
Kuboki, Ryo
Nishino, Hiroshi
Ito, Makoto
Tahara, Makoto
- License Information
-
More Information
Article History
Received: 27 April 2024
Accepted: 30 June 2024
First Online: 23 July 2024
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Tahara reports grants and personal fees from Ono Pharmaceutical and Bayer; and personal fees from MSD, BMS, Merck Biopharma, Pfizer, Rakuten Medical, Lilly, Boehringer Ingelheim, Eisai, Chugai Pharmaceutical, Daiichi-Sankyo, Janssen Pharmaceutical, Genmab, Astra Zeneca, Abbvie and Astellas outside the submitted work. Dr. Enokida reports personal fees from Ono Pharmaceutical, Bayer, MSD, and Merck Biopharma outside the submitted work. Dr. Okano reports personal fees from Ono Pharmaceutical, MSD, BMS, and Merck Biopharma. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
